ZipLine Medical, Inc. was selected as a winner of the Red Herring Top 100 North America award, which recognizes the continent’s most exciting and innovative private technology companies.

Winners were chosen from thousands of entrants in a gamut of verticals, from financial technology to marketing, and medical devices to Internet of things. Companies were judged by industry experts, insiders and journalists on a wide variety of criteria, including financial performance, innovation, business strategy, and market penetration. Red Herring’s editors have been evaluating the world’s startups and tech companies for over two decades and their insights enable them to select firms that will continue on a trajectory to success. Brands such as Alibaba, Google, Kakao, Skype, Spotify, Twitter and YouTube have all been singled out as Red Herring winners in the past.

The Zip® Surgical Skin Closure and PreLoc Wound Closure devices have seen significant adoption in key surgical procedures such as total joint replacement and limb salvage. In addition to the economic benefits these devices provide to the hospital and clinic, the high degree of patient satisfaction they engender has created word of mouth that often drives a patient’s friends and family to request ZipLine devices for their next surgery.

“Adoption of the Zip device in our procedures represents the cutting edge of surgery. Orthopedic patients are becoming more and more educated on the products and techniques that offer the best surgical outcomes, and come to the table expecting these from their surgeon,” said Robert C. Marchand MD, orthopedic surgeon and robotic joint replacement expert in Wakefield, Rhode Island. “The Zip enables us to provide patients with a more comfortable recovery and better cosmetic outcome while reducing surgical procedure time and patient complications that add costs to the healthcare system.

Latest news

Optinose’s XHANCE® Approved by FDA for Chronic Rhinosinusitis without Nasal Polyps
March 15, 2024

Full release here: Optinose’s XHANCE® Approved by FDA for Chronic Rhinosinusitis without Nasal Polyps

GT Medical Technologies Names Per Langoe As CEO
February 20, 2024

Full release here: GT Medical Technologies, Inc. Names Per Langoe As CEO

MVM invests in icotec
January 24, 2024

ALTSTAETTEN, Switzerland and EAST HARTFORD, Conn., Jan. 24, 2024 /PR Newswire/ — icotec ag, the leading company in the field of innovative spinal […]

MVM invests in Gynesonics
November 1, 2023

REDWOOD CITY, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) — Gynesonics® Inc., a women’s healthcare company focused on the development of […]

SkyCell Featured in TechCrunch
October 31, 2023

Full release here: SkyCell raises $57M at a $600M valuation to build smart containers for pharmaceutical transport | TechCrunch

MVM invests in BioProtect
September 27, 2023

TZUR IGAL, Israel, Sept. 27, 2023 /PRNewswire/ — BioProtect Ltd, a private Med Tech company focused on providing innovative, biodegradable spacing solutions, announced today the […]

VitalConnect Secures over $30 Million in Oversubscribed Series F Financing
July 18, 2023

SAN JOSE, Calif.–(BUSINESS WIRE)–VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced closing on an oversubscribed […]

MVM invests in CurvaFix
July 14, 2023

BELLEVUE, Wash.–(BUSINESS WIRE)–CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the close of […]

Vertos Medical Secures $26 Million to Expand Commercialization Efforts and Develop Breakthrough Treatments for Chronic Low Back Pain
June 7, 2023

ALISO VIEJO, Calif., June 7, 2023 /PRNewswire/ — Vertos Medical Inc., a leader in the development of innovative, minimally invasive treatments for […]

eXmoor pharma completes $35 million Series A to expand cell and gene therapy manufacturing capabilities
May 30, 2023

New GMP facility to complete eXmoor’s transition from consultancy to one-stop global cell and gene therapy partner Bristol, UK, May […]